Where standard playbooks fail in Clinical Trial Tech Marketing Agency.
Clinical trials tech buyers are trial operations directors, principal investigators, and CROs. Trial-ops directors care about patient enrollment velocity; PIs care about protocol adherence; CROs care about billable-hour recovery. Generic “eClinical” content fails all three.
How MV3 builds it differently.
MV3 builds enrollment-velocity dashboards, protocol-adherence case studies, and CRO billing-recovery ROI models. Layers ABM outbound to top 50 CROs and academic medical centers with role-tailored sequences.
What outcomes look like.
- 12+ enrollment-velocity case studies
- 4 CRO ABM plays per quarter
- $4.2M attributed pipeline from academic medical centers
- Protocol-adherence dashboard now industry benchmark
The engagement structure.
Growth AI is our productized 12-month retainer at $5,997/mo. Strategy and implementation are bundled — never separate line items. Every content asset, workflow, and dashboard you receive is yours to keep, forever. If you cancel in month 9, month 10 doesn’t go dark — you own the engine.
For companies wanting a diagnostic first, our GEO Audit ($997) ships in 5 business days and shows exactly where you rank in ChatGPT, Perplexity, Gemini, and Claude for your buyer’s category prompts.
What buyers ask us.
How does MV3’s approach differ from a typical marketing retainer?
You own every asset, workflow, and template we build. When the engagement ends, the engine keeps compounding — because it’s yours, not licensed from us.
What’s the shortest engagement?
12-month minimum for Growth AI retainers. Audits are one-time deliverables. Enterprise engagements are 18-36 months typically.
Do you work with venture-backed companies specifically?
Yes — series A through pre-IPO. Bootstrap and PE-backed too. Not startups pre-revenue or pre-product-market-fit.
What’s included at the $5,997/mo tier?
15-30 content assets per month (industry-authentic, not templated), 500-account ABM outbound with 12-touch sequences, weekly pipeline-dollar reporting, custom n8n workflows on your stack, and unlimited Slack access to our team.
Why the standard playbook fails here.
The buying committee in this category has vertical-specific pain and jargon. Generic content and pattern-match ABM lists get filtered out. MV3 builds industry-authentic content, maps the real buying committee, and instruments the pipeline for outcome accountability - not activity.
The engagement.
- Discovery: ICP interviews with 5-8 buyers in the category (Week 1-2)
- Content system: 15-30 industry-authentic assets shipped per month (Month 1-3)
- ABM outbound: 500 named accounts with 12-touch cross-channel sequences (Month 2+)
- Analytics: pipeline-dollar reporting, not vanity ranking metrics (weekly)
- Ownership: every workflow and asset yours to keep, forever
